Back to top
more

Virtus LifeSci Biotech Clinical Trials ETF: (BBC)

(Real Time Quote from BATS) As of Jun 22, 2018 03:57 PM ET

 Add to portfolio

$34.27 USD

34.27
18,251

-0.17 (-0.11%)

Volume: 18,251

Zacks ETF Rank 2 - Buy   2      

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 34.44
Open 74.54
Bid 29.70
Ask 38.87
Day Low-High 33.85-34.74
52wk Low-High 23.22-36.25
Volume 18,251
NAV (month end) 34.67
Premium (+)/Discount (-) (month end)-0.23

Zacks Premium Research for BBC

Zacks ETF Rank Buy 2
ETF Risk High

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.79%
Dividend (Yield) $2.31 (3.08%)
Issuer NEWFLEET ASSET MANAGEMENT

Benchmark for BBC

LIFESCI BIOTECH CLINICAL TRIALS INDEX

The LifeSci Biotechnology Clinical Trials Index is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering that is in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development.

Fund Summary for BBC

VIRTUS LIFESCI BIOTECH CLINCL TRIALS ETF

The Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index.